Publications
Westat researchers publish on a wide array of topics that further our understanding of the field and focus on improving lives through research. Selected publications that communicate our findings, including books, peer-reviewed articles and technical reports, conference proceedings, and more are presented here.
2022
Friesen M.C., Hung F., Xie S., Viet S.M., Deziel N.C., Locke S.J., Josse P.R., Sauvé J.F., Andreotti G., Thorne P.S., Beane-Freeman L.E., and Hofmann J.N. (2022).
A task-specific algorithm to estimate occupational (1→3)-ß-D-glucan exposure for farmers in the Biomarkers of Exposure and Effect in Agriculture Study.
Annals of Work Exposures and Health, 66(8), 974-984.
Miller M.J., Himschoot A., Fitch N., Jawalkar S., Freeman D., Hilton C., Berney K., Guy G.P., Benoit T.J., Clarke K.E.N., Busch M.P., Opsomer J.D., Stramer S.L., Hall A.J., Gundlapalli A.V., MacNeil A., McCord R., Sunshine G., Howard-Williams M., Dunphy C., and Jones J.M. (2022).
Association of trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroprevalence and state-issued nonpharmaceutical interventions: United States, 1 August 2020 to 30 March 2021.
Clinical Infectious Diseases, 75(Suppl. 2), S264-S270.
Busch M.P., Stramer S.L., Stone M., Yu E.A., Grebe E., Notari E., Saa P., Ferg R., Molina Manrique I., Weil N., Fink R.V., Levy M.E., Green V., Cyrus S., Williamson P.C., Haynes J., Groves J., Krysztof D., Custer B., Kleinman S., Biggerstaff B.J., Opsomer J.D., and Jones J.M. (2022).
Population-weighted seroprevalence from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, vaccination, and hybrid immunity among US blood donations from January to December 2021.
Clinical Infectious Diseases, 75(Suppl. 2), S254-S263.
Campione J.R., Ritchie N.D., Fishbein H.A., Mardon R.E., Johnson M.C., Pace W., Birch R.J., Seeholzer E.L., Zhang X., Proia K., Siegel K.R., and McKeever Bullard K. (2022).
Use and impact of type 2 diabetes prevention interventions.
American Journal of Preventive Medicine, 63(4), 603-610.
Link-Gelles R., Levy M.E., Gaglani M., Irving S.A., Stockwell M., Dascomb K., DeSilva M.B., Reese S.E., Liao I.-C., Ong T.C., Grannis S.J., McEvoy C., Patel P., Klein N.P., Hartmann E., Stenehjem E., Natarajan K., Naleway A.L., Murthy K., Rao S., Dixon B.E., Kharbanda A.B., Akinseye A., Dickerson M., Lewis N., Grisel N., Han J., Barron M.A., Fadel W.F., Dunne M.M., Goddard K., Arndorfer J., Konatham D., Valvi N.R., Currey J.C., Fireman B., Raiyani C., Zerbo O., Sloan-Aagard C., Ball S.W., Thompson M.G., and Tenforde M.W. (2022).
Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 omicron BA.1 and BA.2/BA.2.12.1 sublineages predominated — VISION Network, 10 States, December 2021–June 2022.
Morbidity and Mortality Weekly Report, 71(29), 931-939.
Slotman B.A., Stinchcomb D.G., Powell-Wiley T.M., Ostendorf D.M., Saelens B.E., Gorin A.A., Zenk S.N., and Berrigan D. (2022).
Environmental data and methods from the Accumulating Data to Optimally Predict Obesity Treatment (ADOPT) core measures environmental working group.
Data in Brief, 41, 108002.
Bond G.R., Al-Abdulmunem M., Ressler D.R., Gade D.M., and Drake R.E. (2022).
A randomized controlled trial of an employment program for veterans transitioning from the military: Two-year outcomes.
Administration and Policy in Mental Health and Mental Health Services Research, 49(6), 1072-1083.
Caminiti C., Bryce J., Riva S., Ng D., Diodati F., Iezzi E., Sparavigna L., Novello S., Porta C., Del Mastro L., Procopio G., Cinieri S., Falzetta A., Calabrò F., Lorusso V., Cogoni A.A., Tortora G., Maruzzo M., Passalacqua R., Cognetti F., Adamo V., Capelletto E., Ferrari A., Bagnalasta M., Bassi M., Nicelli A., De Persis D., D'Acunti A., Iannelli E., Perrone F., and Mitchell S.A. (2022).
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE).
Tumori Journal.
